An Innovative Home Stroke Rehabilitation and Monitoring System

描述(由申请人提供)：本提案展示了一种新的医疗保健提供系统，该系统具有显著促进中风康复监测和治疗的潜力。广泛的长期目标是为农村和服务不足地区的人们提供可获得的、负担得起的中风护理。一个主要的公共卫生问题是中风幸存者接受的治疗质量和数量上的差异，这是基于他们离主要大都市医疗中心的距离。这项建议对中风患者监测和提供最先进的中风治疗的系统进行了评估，以确保农村居民能够获得。这一全面的康复提供系统利用基于网络的平台来存储和检索患者信息，并结合可远程监控的易于使用的机器人治疗设备。收集的数据被自动输入系统并发送到数据中心(对用户透明)，在那里由临床医生通过安全网站监控信息。为了演示系统的功能，使用了现有的用户友好的家庭兼容中风治疗机器人设备。设计了一项随机、对照、多点的临床试验，以评估这一组合对中风幸存者的受控康复治疗与远程保健组件。该模型可以在未来推广，根据特定患者的需要使用其他基于家庭的治疗和监测设备。通过使用这些设备促进有效的家庭治疗将有助于确定功能独立和养老院安置之间的区别。临床试验将招募96名中风患者，并在家中治疗三个月。这些重要的考虑因素结合了提供服务的现代技术和节省成本的潜力。在相对较短的时间内，这些进展将对向数百万农村中风幸存者提供中风治疗产生重大有益影响。动力肌肉公司是一家新兴的公司，正在开发最先进的治疗设备，从根本上改善中风或创伤性脑损伤(TBI)等神经损伤患者的康复。作为一家初创阶段的医疗器械公司，我们经常寻求私人资金来支持增长目标。这项提议的资金不仅将使KMI能够保留和增加四名全职研发人员，而且还将促进来自私人投资界的额外资金，以加快创新远程康复疗法的市场部署。这一战略具有为中风患者提供可获得的、负担得起的康复护理的新水平的现实能力。据估计，目前的这项提案还将在克利夫兰诊所和埃默里大学之间创造或保留四个工作岗位。 公共卫生相关性：这项研究的目的是评估一种为中风患者提供可获得的、负担得起的中风护理的治疗交付系统。用户友好的家庭治疗机器人和远程康复系统相结合，以监测和提供农村和服务不足地区的患者可以获得的治疗。

DESCRIPTION (provided by applicant): This proposal demonstrates a novel healthcare delivery system that has the potential to significantly advance stroke rehabilitation monitoring and therapy. The broad, long-term objective is to provide accessible, affordable stroke care for people in rural and underserved areas. A major public health issue is the variability in the quality and quantity of treatment that stroke survivors receive based on their proximity to major metropolitan medical centers. This proposal evaluates a system of stroke patient monitoring and delivery of state-of-the-art stroke therapy for that is accessible for rural residents. This comprehensive rehabilitation delivery system utilizes Web-based platforms for storage and retrieval of patient information in conjunction with easy-to-use robot therapy devices that can be remotely monitored. Collected data are automatically entered into the system and sent to a data center (transparent to the user), where the information is monitored by a clinician through a secure website. To demonstrate the functionality of the system, an existing user-friendly home-compatible stroke therapy robotic device is utilized. A randomized, controlled, multisite clinical trial is designed to evaluate this combination of controlled rehabilitation therapy for stroke survivors with telehealth components. The model can be generalized in the future with the use of other home-based therapy and monitoring devices as needed for a specific patient. Fostering effective home treatments through the use of these devices will help determine the difference between functional independence and nursing home placement. The clinical trial will enroll 96 stroke patients and treat them at home for three months. These important considerations combine contemporary technology for service delivery and the potential for cost-savings. In a relatively short time, these advances will have a major beneficial impact on the delivery of stroke therapy to millions of rural stroke survivors. Kinetic Muscles, Inc. is an emerging company developing state-of-the-art therapy devices to fundamentally improve rehabilitation for people with neurologic injury such as stroke or traumatic brain injury (TBI). As an early stage medical device company, we regularly seek private funding to support growth objectives. Funding of this proposal would not only allow KMI to retain and add four full-time research and development personnel but would also facilitate additional funding from the private investment community to accelerate market deployment of innovative telerehabilitation therapy. This strategy has the realistic capability to provide a new level of accessible, affordable rehabilitative care for stroke patients. It is estimated that this current proposal will also create or retain four jobs between the Cleveland Clinic and Emory University. PUBLIC HEALTH RELEVANCE: The purpose of this research is to evaluate a therapy delivery system for stroke patients that provide accessible, affordable stroke care. User-friendly home therapy robots and a telerehabilitation system are combined to monitor and provide therapy that is accessible for patients in rural and underserved locations.